Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:April 29, 2013Completed